IP Library Granted Patent US 9,558,325
Granted Patent B2
US 9,558,325 · App. 13/925,685 · Granted Jan 31, 2017

Method and system for determining analyte levels

Inventors: Gary Alan Hayter (Oakland, CA); Erwin Satrya Budiman (Fremont, CA)
Assignee: Abbott Diabetes Care Inc.
G06F19/3487A61B5/002A61B5/14532A61B5/14865A61B5/6849A61B2560/0242
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,558,325
App. No.
13/925,685
Granted
Jan 31, 2017
Kind
B2
Abstract

Methods and apparatus for analyte level estimation are provided for filtering measurement data. In an embodiment, a present predicted analyte level estimate is determined. A present corrected analyte level estimate is determined based at least in part on the determined present predicted analyte level estimate and a received present monitored analyte measurement data. One or more of the medication infusion rate or the received present monitored analyte measurement data are filtered using a rate variance filter, wherein when the medication infusion rate exceeds a predetermined threshold level, the rate variance filter is adjusted from a predetermined setting to a modified setting to be responsive to changes in the present monitored analyte measurement data after a predetermined time period lapses.

Claims (32)

1. A method implemented using one or more processors, comprising:

determining a present predicted analyte level estimate based at least in part on a medication infusion rate and a past predicted analyte level estimate;

determining a present corrected analyte level estimate based at least in part on the determined present predicted analyte level estimate and a received present monitored analyte measurement data; and

filtering, using a rate variance filter, one or more of the medication infusion rate or the received present monitored analyte measurement data;

wherein when the medication infusion rate exceeds a predetermined threshold level, adjusting the rate variance filter from a predetermined setting to a modified setting to be responsive to changes in the present monitored analyte measurement data after a predetermined time period lapses.

2. The method of claim 1 , further including receiving one or more external parameters, wherein determining the present predicted analyte level estimate is based at least in part on the received one or more external parameters.

3. The method of claim 2 , wherein the one or more external parameters includes one or more of a calorie intake amount, a level of physical exertion, or a carbohydrate amount.

4. The method of claim 1 , wherein filtering includes using a Kalman filter.

5. The method of claim 1 , wherein the predetermined time period is measured from a time when the medication infusion rate exceeds the predetermined threshold level.

6. The method of claim 1 , further including reporting the filtered received present monitored analyte measurement data, wherein reporting includes displaying the filtered received present monitored analyte measurement data.

7. An apparatus, comprising:

one or more processing units; and

a memory operatively coupled to the one or more processing units, the memory for storing instructions which, when executed by the one or more processing units, causes the one or more processing units to determine a present predicted analyte level estimate based at least in part on a medication infusion rate and a past predicted analyte level estimate, to determine a present corrected analyte level estimate based at least in part on the determined present predicted analyte level estimate and a received present monitored analyte measurement data, and to filter, using a rate variance filter, one or more of the medication infusion rate or the received present monitored analyte measurement data, wherein when the medication infusion rate exceeds a predetermined threshold level, the one or more processing units are configured to adjust the rate variance filter from a predetermined setting to a modified setting to be responsive to changes in the present monitored analyte measurement data after a first predetermined time period lapses.

8. The apparatus of claim 7 , wherein the memory includes instructions to receive one or more external parameters, and to determine the present predicted analyte level estimate based at least in part on the received one or more external parameters.

9. The apparatus of claim 8 , wherein the one or more external parameters includes one or more of a calorie intake amount, a level of physical exertion, or a carbohydrate amount.

10. The apparatus of claim 8 , wherein when the one or more external parameters exceeds a predetermined threshold level, the rate variance filter is adjusted from the predetermined setting to the modified setting to be more responsive to changes in the present monitored analyte measurement data after a first predetermined time period lapses.

11. The apparatus of claim 10 , wherein the first predetermined time period is measured from the time the one or more external parameters exceeds the predetermined threshold level.

12. The apparatus of claim 7 , wherein the first predetermined time period is measured from a time when the medication infusion rate exceeds the predetermined threshold level.

13. The apparatus of claim 7 , wherein the rate variance filter is adjusted to the predetermined setting after a second predetermined time period lapses, wherein the second predetermined time period is greater than the first predetermined time period.

14. The apparatus of claim 13 , wherein the second predetermined time period is measured from a time the medication infusion rate exceeds the predetermined threshold level.

15. A method implemented using one or more processors, comprising:

determining a rate of change of a monitored analyte level;

anticipating a change in a direction of the rate of change of the monitored analyte level based at least in part on a change in characteristic information of a medication delivery device including one or more of a medication delivery rate, a medication delivery amount, or a medication delivery time period;

evaluating received analyte related signals based on the anticipated change in the direction of the rate of change of the monitored analyte level;

determining an estimated monitored analyte level based at least in part on the received analyte related signals; and

filtering, using a rate variance filter, the received analyte related signals based on the determined rate of change of the monitored analyte level to generate filtered analyte related signals;

wherein when the change in the characteristic information of the medication delivery device exceeds a predetermined threshold level, adjusting the rate variance filter from a predetermined setting to a modified setting to be responsive to changes in the monitored analyte level after a first predetermined time period lapses.

16. The method of claim 15 , further including reporting the generated filtered analyte related signals.

17. The method of claim 16 , wherein reporting the generated filtered analyte related signals includes displaying the generated filtered analyte related signals.

18. The method of claim 15 , wherein anticipating the change in the direction of the rate of change of the monitored analyte level occurs within a predetermined time following the change in the characteristic information.

19. The method of claim 15 , wherein the first predetermined time period is measured from the time the characteristic information of the medication delivery device exceeds the predetermined threshold level.

20. The method of claim 15 , wherein the rate variance filter is adjusted to the predetermined setting after a second predetermined time period lapses, wherein the second predetermined time period is greater than the first predetermined time period, and further wherein the second predetermined time period is measured from the time the medication infusion rate exceeds the predetermined threshold level.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 22, 2014
From: HAYTER, GARY; BUDIMAN, ERWIN S.
To: ABBOTT DIABETES CARE INC.
Reel/Frame 033380/0233 →
Continuity (4)
Continuation 13424291 · Mar 19, 2012
Continuation 12024101 · Jan 31, 2008
Provisional Application 60917873 · May 14, 2007
Related Publication 20130282403A1 · Oct 24, 2013